Holen Sie sich die Stockscreener-App
1.72
3.61%
0.06
Schlusskurs vom Vortag:
$1.66
Offen:
$1.67
24-Stunden-Volumen:
33,128
Relative Volume:
0.06
Marktkapitalisierung:
$6.55M
Einnahmen:
$556.00K
Nettoeinkommen (Verlust:
$-5.28M
KGV:
-0.8037
EPS:
-2.14
Netto-Cashflow:
$-6.23M
1W Leistung:
+12.42%
1M Leistung:
-4.44%
6M Leistung:
-45.22%
1J Leistung:
-58.75%
1-Tages-Spanne:
$1.65
$1.77
1-Wochen-Bereich:
$1.49
$1.82
52-Wochen-Spanne:
$1.28
$6.25
Cyclerion Therapeutics Inc Stock (CYCN) Company Profile
Firmenname
Cyclerion Therapeutics Inc
Sektor
Branche
Telefon
617-621-7722
Adresse
301 BINNEY STREET, CAMBRIDGE, MA
Vergleichen Sie CYCN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CYCN
Cyclerion Therapeutics Inc
|
1.72 | 6.32M | 556.00K | -5.28M | -6.23M | -2.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cyclerion Therapeutics Inc Stock (CYCN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-10-20 | Eingeleitet | Truist | Buy |
| 2021-09-24 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-06-03 | Eingeleitet | Credit Suisse | Neutral |
Cyclerion Therapeutics Inc Aktie (CYCN) Neueste Nachrichten
Cyclerion Therapeutics Inc. (CYCN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Can Cyclerion Therapeutics Inc. stock sustain institutional interestTrade Performance Summary & Safe Swing Trade Setups - Newser
Does Cyclerion Therapeutics Inc. stock trade at a discount to peersWeekly Loss Report & Verified Momentum Watchlists - Newser
How currency fluctuations impact Cyclerion Therapeutics Inc. stockJuly 2025 Sector Moves & Low Risk High Win Rate Stock Picks - Newser
Cyclerion Therapeutics (CYCN) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Is Cyclerion Therapeutics Inc. stock attractive for growth ETFsPortfolio Risk Report & Free Long-Term Investment Growth Plans - Newser
Cyclerion Receives Milestone Payment from Akebia - TipRanks
Cyclerion Therapeutics Announces Milestone Payment from Akebia - TradingView
Akebia Therapeutics, Inc. Initiates Phase 2 Clinical Trials for the Treatment of Focused Segmental Glomerulosclerosis Using Praliciguat - marketscreener.com
Cyclerion Therapeutics, Inc. Announces Revision in Its Stock Evaluation Amid Financial Trends - Markets Mojo
How strong is Cyclerion Therapeutics Inc. stock balance sheetBond Market & Real-Time Stock Movement Alerts - newser.com
Will Cyclerion Therapeutics Inc. stock maintain growth story2025 Momentum Check & Smart Swing Trading Techniques - newser.com
Smart tools for monitoring Cyclerion Therapeutics Inc.’s price actionStop Loss & Fast Gain Stock Trading Tips - newser.com
What institutional flow reveals about Cyclerion Therapeutics Inc.Quarterly Profit Report & AI Forecasted Entry and Exit Points - newser.com
Combining machine learning predictions for Cyclerion Therapeutics Inc.Weekly Stock Summary & Daily Volume Surge Signals - newser.com
Tick level data insight on Cyclerion Therapeutics Inc. volatilityRecession Risk & Trade Opportunity Analysis - newser.com
Why Cyclerion Therapeutics Inc. stock is recommended by analystsEarnings Performance Report & Fast Entry Momentum Trade Alerts - newser.com
Cyclerion Therapeutics Inc Stock Analysis and ForecastPrice-to-Book Ratio Updates & High Return Wealth Plans - earlytimes.in
What MACD and RSI say about Cyclerion Therapeutics Inc.July 2025 Retail & Risk Adjusted Swing Trade Ideas - newser.com
Is Cyclerion Therapeutics Inc. stock reversal real or fakeJuly 2025 Outlook & Real-Time Stock Price Movement Reports - newser.com
Live market analysis of Cyclerion Therapeutics Inc.Weekly Investment Recap & Expert Curated Trade Ideas - newser.com
Is Cyclerion Therapeutics Inc. stock a top pick in earnings seasonWeekly Stock Report & Short-Term Trading Opportunity Alerts - Fundação Cultural do Pará
Is Cyclerion Therapeutics Inc a good long term investmentLong-Term Growth Stocks & You’ve Never Seen Stock Picks Like These - earlytimes.in
Comparing Cyclerion Therapeutics Inc. in custom built stock radarsWeekly Loss Report & Reliable Price Breakout Alerts - newser.com
Cyclerion Therapeutics, Inc. SEC 10-Q Report - TradingView
Cyclerion Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
[10-Q] Cyclerion Therapeutics, Inc. Quarterly Earnings Report | CYCN SEC FilingForm 10-Q - Stock Titan
Short interest data insights for Cyclerion Therapeutics Inc.Weekly Trend Report & Fast Moving Market Watchlists - newser.com
Prepare Yourself for Liftoff: Cyclerion Therapeutics Inc (CYCN) - Setenews
Insider Stock Buying Reaches US$525.0k On Cyclerion Therapeutics - Yahoo Finance
Can Cyclerion Therapeutics Inc. stock deliver surprise earnings beatJuly 2025 Selloffs & AI Enhanced Trading Alerts - newser.com
EXCLUSIVE: Cycurion Wins $1 Million+ Contract To Modernize Federal Emergency Warning Network - Benzinga
How to monitor Cyclerion Therapeutics Inc. with trend dashboardsForecast Cut & Daily Technical Forecast Reports - newser.com
Finanzdaten der Cyclerion Therapeutics Inc-Aktie (CYCN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):